EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Utility of High‐Sensitivity Cardiac Troponin‐T and N‐Terminal Pro‐B‐Type Natriuretic Peptide to Predict Survival, Quality of Life, and Functional Status Changes After Transcatheter Aortic Valve Implantation

Tyler Andrews, Ahmad Jabri iD, Patrick McBride, David Gelovani iD, Mohamad Beidoun iD, Gennaro Giustino, Stephen Krafchak, Stephen Gladney, Danielle Holmes, Janet F Wyman, Dee Dee Wang iD, Marvin Eng iD und 11 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.039898 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Tyler Andrews und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine Henry Ford Hospital Detroit MI USA. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Natriuretic Peptide, Brain, Peptide Fragments, Troponin T. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiac biomarkers are minimally incorporated into current aortic valve guidelines, except for elevated BNP (B‐type natriuretic peptide) in asymptomatic severe aortic stenosis. This prospective observational cohort studied how pretranscatheter aortic valve implantation (TAVI) NT‐proBNP (N‐terminal proBNP) and hs‐cTnT (high‐sensitivity cardiac troponin T) relate to mortality, quality of life, and functional outcomes after TAVI.

Methods

This is a prospective cohort study of 173 patients undergoing TAVI at a large medical center in the United States between January 1, 2020, and January 1, 2022. NT‐pro‐BNP and hs‐cTnT, Kansas City Cardiomyopathy Questionnaire, 6‐minute walk distance, and mortality were surveilled pre TAVI, and at 30 days, 1 year, and 2 years post TAVI. The patients represented a real‐world cohort of patients receiving TAVI.

Results

Two‐year mortality for the entire cohort was 7.51% (13/173). In univariable analysis, higher baseline NT‐pro‐BNP and hs‐cTnT were predictors of mortality at 2 years after TAVI. After adjusting for covariables, baseline hs‐cTnT demonstrated a clinically meaningful association with mortality ( P =0.058; odds ratio [OR], 2.74 [95% CI, 0.967–7.734]). In multivariable analysis, a combination variable of tertiled baseline hs‐cTnT and NT‐pro‐BNP was a significant predictor of 2‐year mortality; specifically, 2‐year mortality rates stratified by combined score values of 6, 5, 4, 3, and 2 were 16.1%, 13.8%, 7.3%, 0%, and 0%, respectively.

Conclusions

Those with an elevated combination biomarker variable—NT‐pro‐BNP >357 pg/mL and hs‐cTnT >14.1 ng/L—should be most rigorously surveilled and managed before and after TAVI with more frequent and comprehensive outpatient visits for medical optimization of cardiac and noncardiac disease states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementNatriuretic Peptide, BrainPeptide FragmentsTroponin TAortic Valve StenosisQuality of LifeHumansMaleFemaleBiomarkersProspective StudiesAged, 80 and overAgedFunctional StatusPredictive Value of TestsSurvival RateTime Factors

Stichwörter der Autor:innen

aortic valve stenosisbiomarkersbrainnatriuretic peptidetranscatheter aortic valve replacementtroponin

Substanzen

Natriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)Peptide FragmentsTroponin TBiomarkers

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine Henry Ford Hospital Detroit MI USA.
  • College of Human Medicine Michigan State University Detroit MI USA.
  • NCH Rooney Heart Institute, NCH Naples FL USA.
  • Banner - University Medical Center Phoenix Phoenix AZ USA.
  • Division of Behavioral Health Sciences Henry Ford Hospital Detroit Michigan USA.
  • Department of Pathology Henry Ford Health + Michigan State University Health Sciences Detroit Michigan USA.

ORCID-Profile: Ahmad Jabri, David Gelovani, Mohamad Beidoun, Dee Dee Wang, Marvin Eng, Herb Aronow, Dave Lanfear, William O'Neill, Pedro Villablanca, James Lee, Bernard Cook, James McCord, Tiberio M Frisoli

Zitieren

APA

Andrews, T., Jabri, A., McBride, P., Gelovani, D., Beidoun, M., Giustino, G., Krafchak, S., Gladney, S., Holmes, D., Wyman, J. F., Wang, D. D., Eng, M., Aronow, H., Lanfear, D., O'Neill, W., Engel Gonzalez, P., O'Neill, B., Villablanca, P., Lee, J., …, & Frisoli, T. M. (2025). Utility of High‐Sensitivity Cardiac Troponin‐T and N‐Terminal Pro‐B‐Type Natriuretic Peptide to Predict Survival, Quality of Life, and Functional Status Changes After Transcatheter Aortic Valve Implantation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.039898

Vancouver

Andrews T, Jabri A, McBride P, Gelovani D, Beidoun M, Giustino G, et al. Utility of High‐Sensitivity Cardiac Troponin‐T and N‐Terminal Pro‐B‐Type Natriuretic Peptide to Predict Survival, Quality of Life, and Functional Status Changes After Transcatheter Aortic Valve Implantation. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.039898

BibTeX
@article{Andrews2025,
  author = {Andrews, Tyler and Jabri, Ahmad and McBride, Patrick and Gelovani, David and Beidoun, Mohamad and Giustino, Gennaro and Krafchak, Stephen and Gladney, Stephen and Holmes, Danielle and Wyman, Janet F and Wang, Dee Dee and Eng, Marvin and Aronow, Herb and Lanfear, Dave and O'Neill, William and Engel Gonzalez, Pedro and O'Neill, Brian and Villablanca, Pedro and Lee, James and Jacobsen, Gordon and Cook, Bernard and McCord, James and Frisoli, Tiberio M},
  title = {Utility of High‐Sensitivity Cardiac Troponin‐T and N‐Terminal Pro‐B‐Type Natriuretic Peptide to Predict Survival, Quality of Life, and Functional Status Changes After Transcatheter Aortic Valve Implantation},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.039898}
}
Kostenlos starten →